Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Feb;117(2 Suppl Mini-Primer):S456-61.
doi: 10.1016/j.jaci.2005.07.006.

6. Asthma: Factors underlying inception, exacerbation, and disease progression

Affiliations
Review

6. Asthma: Factors underlying inception, exacerbation, and disease progression

Robert F Lemanske Jr et al. J Allergy Clin Immunol. 2006 Feb.

Abstract

Asthma is a heterogeneous disorder that is characterized by variable airflow obstruction, airway inflammation and hyperresponsiveness, and reversibility either spontaneously or as a result of treatment. Multiple causes no doubt exist for both its inception and symptom exacerbation once the disease is established. Factors underlying inception can range from viral respiratory tract infections in infancy to occupational exposures in adults. Factors underlying asthma exacerbations include allergen exposure in sensitized individuals, viral infections, exercise, irritants, and ingestion of nonsteroidal anti-inflammatory agents among others. Exacerbating factors might include one or all of these exposures and vary both among and within patients. Asthma treatment is determined to a large extent after an assessment of severity, which can be variable over time and assessed in 2 domains: impairment (current) and risk (long-term consequences). Unfortunately, despite the availability of effective therapies, suboptimal asthma control exists in many patients on a worldwide basis. The future development of novel therapies and treatment paradigms should address these disparities.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Taussig L.M., Wright A.L., Holberg C.J., Halonen M., Morgan W.J., Martinez F.D. Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol. 2003;111:661–675. - PubMed
    1. Frew A.J. Advances in environmental and occupational disorders. J Allergy Clin Immunol. 2003;111(suppl):S824–S828. - PubMed
    1. Rabe K.F., Adachi M., Lai C.K., Soriano J.B., Vermeire P.A., Weiss K.B. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–47. - PubMed
    1. Sears M.R., Greene J.M., Willan A.R., Wiecek E.M., Taylor D.R., Flannery E.M. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349:1414–1422. - PubMed
    1. Phelan P.D., Robertson C.F., Olinsky A. The Melbourne asthma study: 1964-1999. J Allergy Clin Immunol. 2002;109:189–194. - PubMed

Substances